Suppr超能文献

去甲肾上腺素在麦默通辅助微创切除良性乳腺肿瘤中的应用疗效:一项回顾性研究。

The efficacy of norepinephrine application in Mammotome-assisted minimally invasive resection for benign breast neoplasm: A retrospective study.

作者信息

Sun Yafei, Xu Zipeng, Hu Jing, You Lina, Chen Chaobo

机构信息

Department of General Surgery, Xishan People's Hospital of Wuxi City, Wuxi, 214105, China.

Department of Postpartum Rehabilitation Center, Xishan People's Hospital of Wuxi City, Wuxi, 214105, China.

出版信息

BMC Surg. 2024 Dec 19;24(1):393. doi: 10.1186/s12893-024-02701-y.

Abstract

OBJECTIVE

Although Mammotome-assisted minimally invasive resection (MAMIR) has been widely accepted for treating breast benign nodules, the procedure remains very technical and challenging. The present study aimed to assess the efficacy of norepinephrine application in MAMIR concerning intraoperative hemorrhage, postoperative pain and postoperative hospitalization.

METHODS

A total of 306 patients with breast nodules admitted at the Xishan people's Hospital of Wuxi City between June 2021 and July 2023 were included in this retrospective cohort study. The patient's age, comorbidities (hypertension and diabetes), and characteristics of the breast nodule (number, unilateral or bilateral nature, inner quadrant volume and total volume) were all meticulously documented. Operation time, intraoperative hemorrhage, postoperative hospitalization and Visual analogue scale(VAS) score (postoperative 6-hour pain score) were recorded. Based on the application of norepinephrine, patients were categorized into non-NPP(norepinephrine) and NPP group. Univariate and multivariate analyses were performed to estimate the odds ratio (OR) and the 95% confidence intervals (CIs) for outcomes.

RESULTS

A total of 155 who accepted MAMIR were included in this study. The NPP group exhibited reduced intraoperative bleeding, diminished postoperative pain, and a shorter duration of hospitalization (p < 0.05). Univariable analysis indicated that usage of norepinephrine during operation helped to reduce intraoperative hemorrhage (OR = 0.14, 95%CI: 0.07-0.31), alleviate postoperative pain(OR = 0.03, 95%CI: 0.01-0.09) and shorten hospital stay(OR = 0.50, 95%CI: 0.26-0.95). Furthermore, multivariate analysis identified the usage of norepinephrine during MAMIR as an independent factor associated with reducing intraoperative hemorrhage (OR = 0.11, 95%CI: 0.05-0.26) and relieving postoperative pain (OR = 0.02, 95%CI: 0.004-0.08) after adjusting for other factories.

CONCLUSIONS

Norepinephrine could help to reduce postoperative hospitalization and intraoperative hemorrhage, also relieve postoperative pain for breast benign nodules resection, which was an independent protective factor for relieving postoperative pain and reducing intraoperative hemorrhage.

摘要

目的

尽管麦默通辅助微创切除术(MAMIR)已被广泛用于治疗乳腺良性结节,但该手术技术要求高且具有挑战性。本研究旨在评估去甲肾上腺素在MAMIR中对术中出血、术后疼痛和术后住院时间的影响。

方法

本回顾性队列研究纳入了2021年6月至2023年7月在无锡市锡山区人民医院收治的306例乳腺结节患者。详细记录患者的年龄、合并症(高血压和糖尿病)以及乳腺结节的特征(数量、单侧或双侧性质、内象限体积和总体积)。记录手术时间、术中出血量、术后住院时间和视觉模拟评分(VAS)(术后6小时疼痛评分)。根据去甲肾上腺素的应用情况,将患者分为非去甲肾上腺素组(non-NPP)和去甲肾上腺素组(NPP)。进行单因素和多因素分析以估计结局的比值比(OR)和95%置信区间(CIs)。

结果

本研究共纳入155例行MAMIR的患者。NPP组术中出血减少、术后疼痛减轻且住院时间缩短(p < 0.05)。单因素分析表明,术中使用去甲肾上腺素有助于减少术中出血(OR = 0.14,95%CI:0.07 - 0.31)、减轻术后疼痛(OR = 0.03,95%CI:0.01 - 0.09)并缩短住院时间(OR = 0.50,95%CI:0.26 - 0.95)。此外,多因素分析确定,在调整其他因素后,MAMIR术中使用去甲肾上腺素是与减少术中出血(OR = 0.11,95%CI:0.05 - 0.26)和减轻术后疼痛(OR = 0.02,95%CI:0.004 - 0.08)相关的独立因素。

结论

去甲肾上腺素有助于减少乳腺良性结节切除术后的住院时间和术中出血,还能减轻术后疼痛,是减轻术后疼痛和减少术中出血的独立保护因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de20/11660863/979dc388d137/12893_2024_2701_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验